Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic

Chia Siang Kow; Syed Shahzad Hasan

doi:10.1080/14779072.2021.1842050

Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	99-100
Number of pages	2
Journal	Expert Review of Cardiovascular Therapy
Volume	19
Issue number	1
Early online date	12 Nov 2020
DOIs	https://doi.org/10.1080/14779072.2021.1842050
Publication status	Published - 1 Jan 2021

Access to Document

10.1080/14779072.2021.1842050Licence: Unspecified

Cite this

@article{4821bcfb6098405d8a855f36a8f56ff3,

title = "Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic",

keywords = "Angiotensin-II receptor blockers, angiotensin converting enzyme inhibitors, hypertension, COVID-19",

author = "Kow, {Chia Siang} and Hasan, {Syed Shahzad}",

year = "2021",

month = jan,

day = "1",

doi = "10.1080/14779072.2021.1842050",

language = "English",

volume = "19",

pages = "99--100",

journal = "Expert Review of Cardiovascular Therapy",

issn = "1477-9072",

publisher = "Expert Reviews Ltd.",

number = "1",

}

TY - JOUR

T1 - Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic

AU - Kow, Chia Siang

AU - Hasan, Syed Shahzad

PY - 2021/1/1

Y1 - 2021/1/1

KW - Angiotensin-II receptor blockers

KW - angiotensin converting enzyme inhibitors

KW - hypertension

KW - COVID-19

UR - http://www.scopus.com/inward/record.url?scp=85096102626&partnerID=8YFLogxK

U2 - 10.1080/14779072.2021.1842050

DO - 10.1080/14779072.2021.1842050

M3 - Editorial

VL - 19

SP - 99

EP - 100

JO - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

SN - 1477-9072

IS - 1

ER -

Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic

Access to Document

Other files and links

Sharing the evidence to help tackle COVID-19

Cite this

Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic

Access to Document

Other files and links

Press / Media

Sharing the evidence to help tackle COVID-19

Cite this